Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
01/2010
01/28/2010WO2010011653A1 Tricyclic heterocycle derivatives as histamine h3 antagonists
01/28/2010WO2010011314A1 Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
01/28/2010WO2010010933A1 Heterocyclidene-n-(3,4-dihydro-2(1h)-quinazolin-5-yl) acetamide derivative
01/28/2010WO2010010150A1 Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
01/28/2010WO2010010014A1 4,5-dihydro-oxazol-2-yl derivatives
01/28/2010WO2010009847A1 Heterocyclically substituted amides, method for the production thereof, and use as herbicides
01/28/2010WO2009140089A3 Sulfone compounds which modulate the cb2 receptor
01/28/2010WO2008137816A8 Tricyclic compounds as matrix metalloproteinase inhibitors
01/28/2010US20100022773 Apoptosis promoters
01/28/2010US20100022772 Process for the synthesis of biaryl oxazolidnones
01/28/2010US20100022769 Novel polynitrogenated systems as anti-hiv agents
01/28/2010US20100022597 2-adamantyl-butyramide derivatives as selective 11beta-hsd1 inhibitors
01/28/2010US20100022590 Novel compounds
01/28/2010US20100022559 Bisoximes as fungicides
01/28/2010US20100022546 Adamantyl diamide derivatives and uses of same
01/28/2010US20100022545 Metabotropic Glutamate Receptor Isoxazole Ligands and Their Use as Potentiators - 286
01/28/2010US20100022544 Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof
01/28/2010US20100022541 Chemical inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors
01/28/2010US20100022540 Triazole derivatives ii
01/28/2010US20100022539 Isoxazole Compounds as Histamine H3 modulators
01/28/2010US20100022538 5-fluoro pyrimidine derivatives
01/28/2010US20100022537 I-pheny 1-3,4-dihydropyrimidin-2(1h)-one derivatives and their use
01/28/2010US20100022535 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 Inhibitors
01/28/2010US20100022534 2-benzimidazolyl-6-morpholino-4- (azetidine, pyrrolidine, piperidine or azepine) pyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
01/28/2010US20100022533 Compositions and methods for inducing cell dedifferentiation
01/28/2010US20100022530 Tetrahydrobenzoisoxazole and tetrahydroindazole derivatives as modulators of the mitotic motor protein
01/28/2010US20100022529 Amidophenoxyindazoles useful as inhibitors of c-met
01/28/2010US20100022528 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
01/28/2010US20100022527 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral diseases
01/28/2010US20100022522 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS
01/28/2010US20100022521 Compounds
01/28/2010US20100022518 Novel heterocyclyl compounds
01/28/2010US20100022515 Compounds and compositions as modulators of gpr119 activity
01/28/2010US20100022513 Organic compounds
01/28/2010US20100022506 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
01/28/2010US20100019657 Novel organic electroluminescent compounds and organic electroluminescent device using the same
01/28/2010CA2731869A1 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
01/28/2010CA2730499A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
01/28/2010CA2729998A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
01/28/2010CA2729993A1 Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
01/28/2010CA2728480A1 4,5-dihydro-oxazol-2-yl derivatives
01/27/2010EP2147919A1 Heterocyclic substituted amides, method for their manufacture and their use as herbicides
01/27/2010EP2146985A1 Heterocyclic compounds and their methods of use
01/27/2010EP2146984A1 Hepatitis c virus inhibitors
01/27/2010EP2146983A1 Pyrazoles useful in the treatment of inflammation
01/27/2010EP2146980A2 Histamine h3 receptor ligands comprising a cyclobutoxy group
01/27/2010EP2146779A1 Sulfonyl amide derivatives for the treatment of abnormal cell growth
01/27/2010EP1919903B1 Bicyclic bisamide derivatives and use thereof as insecticides
01/27/2010EP1893581B1 Substituted arylpyrazoles for use against parasitites
01/27/2010CN101633645A N3 alkylated benzimidazole derivatives as mek inhibitors
01/27/2010CN101633644A N3 alkylated benzimidazole derivatives as mek inhibitors
01/27/2010CN100584840C Substituted heterocyclic compounds and uses thereof
01/26/2010US7652150 [2-(4-Fluoro-]. H-indol-3-ylsulfanyl)benzyl]dimethyl amine; depression, anxiety disorders including general anxiety disorder, social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder, panic disorder, panic attacks
01/26/2010US7652144 Compounds as PDE IV and TNF inhibitors
01/26/2010US7652142 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
01/26/2010US7652141 Immunosuppressants, analgesics, antiinflammatory agents
01/26/2010US7652135 Compositions useful as inhibitors of protein kinases
01/26/2010US7652134 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral; contacting the corresponding ester with an amine and a Lewis acid
01/26/2010US7652061 (R)-1-{2-[3-(5-Methyl-2-pheny-oxazol-4-ylmethoxy)-phenyl]-acetyl}-pyrrolidine-2-carboxylic acid; dyslipidemia, hyperlipidemia, hypercholesteremia, or type-2 diabetes
01/26/2010US7652051 3-amino-benzo[1,2,4]triazine-7-ol-1-oxide; 4-[3-(4-chloro-phenylamino)-benzo[1,2,4]triazin-7-yloxy]-pyridine-2-carboxylic acid methylamide trifluoroacetate salt; modulation of the MAPK pathway; cancer
01/26/2010US7652041 Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity
01/26/2010US7652031 Compounds which mimic the chemical and biological properties of discodermolide
01/26/2010US7652021 (2S)-4,4-difluoro-1-{N-[3-(pyrimidin-2-ylamino)-1-adamantyl]glycyl}pyrrolidine-2-carbonitrile; dipeptidyl peptidase IV enzyme inhibitors; non-insulin dependent diabetes mellitus
01/26/2010US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction
01/26/2010CA2430579C Isoindolin-1-one glucokinase activators
01/26/2010CA2403686C Substituted piperidines as melanocortin receptor agonists
01/26/2010CA2350031C N-arylsulfonylamino acid omega-amides
01/21/2010WO2010009212A1 Niacin derivatives useful to treat metabolic syndromes
01/21/2010WO2010009183A1 Pyridone and pyridazone analogues as gpr119 modulators
01/21/2010WO2010009166A1 Oxindolyl inhibitor compounds
01/21/2010WO2010009029A2 Methods for the preparation of azole compounds
01/21/2010WO2010008734A2 Methods of Preparing Imidazole-Based Bicyclic Compounds
01/21/2010WO2010008733A2 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use
01/21/2010WO2010008081A1 Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter
01/21/2010WO2010007966A1 Azole compound
01/21/2010WO2010007756A1 Pyridine derivative having ttk inhibition activity
01/21/2010WO2010007382A1 Benzazepine derivatives and their use as hstamine h3 antagonists
01/21/2010WO2010007120A1 Pyridazine derivatives as smo inhibitors
01/21/2010WO2010007046A2 Organic compounds
01/21/2010WO2010006945A1 Substituted indolyl and indazolyl derivatives and uses thereof
01/21/2010WO2010006944A1 Aminotetrahydroindazoloacetic acids
01/21/2010WO2009131493A3 5-hydroxy-4-aminomethyl-1-cyclohexane or (cycloheptyl)--3-alkoxycarbonyl indole derivatives, pharmaceutically acceptable antiviral salts thereof and a method for the production thereof
01/21/2010WO2009129954A3 2-[(1h-pyrazole-4-ylmethyl)-sulfonyl]-oxazole derivatives, 2-[(1h-pyrazole-4-ylmethyl)-sulfanyl]-oxazole derivatives, and chiral 2-[(1h-pyrazole-4-ylmethyl)-sulfinyl]-oxazole derivatives, methods for the production thereof, and use thereof as herbicides and plant growth regulators
01/21/2010WO2009128661A3 A novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof
01/21/2010WO2009120660A3 Substituted pyridoxazines
01/21/2010WO2009046841A8 Piperidine and piperazine derivatives for treating tumours
01/21/2010US20100016609 Methods for the preparation of azole compounds
01/21/2010US20100016586 Therapeutic compounds and their use in cancer
01/21/2010US20100016585 Phosphorus-containing bisphenols and preparing method thereof
01/21/2010US20100016584 Such as N-((4,6-dimethoxypyrimidin-2-yl)aminocarbonyl)-3-chloro-1-methyl-4-(5-methyl-5H,6H-1,4,2-dioxadin-3-yl)pyrazole-5-sulfonamide; for rice, wheat, and barley
01/21/2010US20100016354 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibitory activity
01/21/2010US20100016335 Novel aminopyridine derivatives having aurora a selective inhibitory action
01/21/2010US20100016320 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
01/21/2010US20100016319 Arylmethylene urea derivative and use thereof
01/21/2010US20100016318 Anthranilamide inhibitors of aurora kinase
01/21/2010US20100016317 Hiv inhibiting 6-substituted pyrimidines
01/21/2010US20100016316 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
01/21/2010US20100016315 Iminopyridine Derivative and Use Thereof
01/21/2010US20100016314 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv
01/21/2010US20100016312 Substituted indolyl and indazolyl derivatives and uses thereof